menu
    • menu

    Company profile for Eyevance Pharmaceuticals LLC

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We’re always working to identify unique collaborative opportunities in the ophthalmic space and have the experience and agility to execute. Eyevance Pharmaceuticals was founded in September 2017 by Jerry St. Peter and Jason Werner. As accomplished entrepreneurs with ophthalmic expertise, their track record of success with both established and vanguard pharmacological products informs the company’s direction. Based in Fort ...
    We’re always working to identify unique collaborative opportunities in the ophthalmic space and have the experience and agility to execute. Eyevance Pharmaceuticals was founded in September 2017 by Jerry St. Peter and Jason Werner. As accomplished entrepreneurs with ophthalmic expertise, their track record of success with both established and vanguard pharmacological products informs the company’s direction. Based in Fort Worth, Texas, the Eyevance team has established working relationships with key opinion leaders (KOLs) whose industry knowledge spans from the clinic to the classroom at most ophthalmic institutions in the United States.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eyevance Pharmaceuticals LLCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    777 Taylor Street, Suite 1050 Fort Worth, TX 76102
    Telephone
    Telephone
    (817) 677-6120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eyevance.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eyevance-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinigen signs exclusive agreement with Eyevance Pharmaceuticals
    Clinigen signs exclusive agreement with Eyevance Pharmaceuticals

    05 Aug 2021

    // INVESTEGATE3

    https://www.investegate.co.uk/clinigen-group-plc--clin-/rns/clinigen-signs-exclusive-agreement-with-eyevance/202108050700066262H/

    INVESTEGATE3
    05 Aug 2021
    Share Share
    Eyevance Pharmaceuticals Acquires TOBRADEX® ST and NATACYN®
    Eyevance Pharmaceuticals Acquires TOBRADEX® ST and NATACYN®

    17 Oct 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eyevance-pharmaceuticals-acquires-tobradex-st-and-natacyn-300939668.html

    PR NEWSWIRE
    17 Oct 2019
    Share Share
    Eyevance Pharmaceuticals Executes Strategic Transaction
    Eyevance Pharmaceuticals Executes Strategic Transaction

    24 Oct 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eyevance-pharmaceuticals-executes-strategic-transaction-300737063.html

    PR NEWSWIRE
    24 Oct 2018
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search